Related references
Note: Only part of the references are listed.Analyzing adverse drug reaction using statistical and machine learning methods A systematic review
Hae Reong Kim et al.
MEDICINE (2022)
Select drug-drug interactions with colchicine and cardiovascular medications: A review
Dave L. Dixon et al.
AMERICAN HEART JOURNAL (2022)
Potentially inappropriate medication use, polypharmacy, and falls among hospitalized patients
Shan-Jen Li et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2022)
Rosuvastatin and Colchicine combined myotoxicity: lessons to be learnt
Nikolaos Sabanis et al.
CEN CASE REPORTS (2021)
Adverse events of colchicine for cardiovascular diseases: a comprehensive meta-analysis of 14 188 patients from 21 randomized controlled trials
Alessandro Andreis et al.
JOURNAL OF CARDIOVASCULAR MEDICINE (2021)
Assessment of Physician's Knowledge of Potential Drug-Drug Interactions: An Online Survey in China
Jing Yuan et al.
FRONTIERS IN MEDICINE (2021)
Evidence of Clinically Meaningful Drug-Drug Interaction With Concomitant Use of Colchicine and Clarithromycin
Lorenzo Villa Zapata et al.
DRUG SAFETY (2020)
Use of the French healthcare insurance database to estimate the prevalence of exposure to potential drug-drug interactions
Cecile Souty et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Prescription of Colchicine with Other Dangerous Concomitant Medications: A Nation-Wide Survey Using the Japanese Claims Database
Shungo Imai et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2020)
Drug interactions with colchicine, are the contraindications well respected? A descriptive study of prescriptions in Brittany based on data from the French National Health Data System
Marion Girard de Courtilles et al.
THERAPIE (2020)
Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials
Sarah Stewart et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Structured override reasons for drug-drug interaction alerts in electronic health records
Adam Wright et al.
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION (2019)
Analysis of Drug-Drug Interactions in Swiss Claims Data Using Tizanidine and Ciprofloxacin as a Prototypical Contraindicated Combination
Annika M. Jodicke et al.
ANNALS OF PHARMACOTHERAPY (2018)
Colchicine: an ancient drug with novel applications
B. Dasgeb et al.
BRITISH JOURNAL OF DERMATOLOGY (2018)
A Critical Evaluation of Safety Signal Analysis Using Algorithmic Standardised MedDRA Queries
Carolyn Tieu et al.
DRUG SAFETY (2018)
Empirical estimation of under-reporting in the US Food and Drug Administration Adverse Event Reporting System (FAERS)
Yasser M. Alatawi et al.
EXPERT OPINION ON DRUG SAFETY (2017)
Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis
Lars G. Hemkens et al.
HEART (2016)
A curated and standardized adverse drug event resource to accelerate drug safety research
Juan M. Banda et al.
SCIENTIFIC DATA (2016)
Colchicine-Update on mechanisms of action and therapeutic uses
Ying Ying Leung et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2015)
Colchicine levels in chronic kidney diseases and kidney transplant recipients using tacrolimus
Anara Amanova et al.
CLINICAL TRANSPLANTATION (2014)
Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery
G. Niklas Noren et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2013)
Normal QT dispersion in colchicine-resistant familial Mediterranean fever (FMF)
Udi Nussinovitch et al.
CLINICAL RHEUMATOLOGY (2012)
Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavir
Clara T. M. M. de Kanter et al.
ANTIVIRAL THERAPY (2011)
Novel Evidence-Based Colchicine Dose-Reduction Algorithm to Predict and Prevent Colchicine Toxicity in the Presence of Cytochrome P450 3A4/P-Glycoprotein Inhibitors
Robert A. Terkeltaub et al.
ARTHRITIS AND RHEUMATISM (2011)
Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database
Jean-Louis Montastruc et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys
A. J. Avery et al.
HEALTH TECHNOLOGY ASSESSMENT (2011)
Mining multi-item drug adverse effect associations in spontaneous reporting systems
Rave Harpaz et al.
BMC BIOINFORMATICS (2010)
Colchicine poisoning: the dark side of an ancient drug
Yaron Finkelstein et al.
CLINICAL TOXICOLOGY (2010)
Colchicine Revisited
Anupama Bhat et al.
CONTEMPORARY CHALLENGES IN AUTOIMMUNITY (2009)
Rhabdomyolysis in an HIV-Infected Patient on Anti-Retroviral Therapy Precipitated by High-Dose Pravastatin
Nasser Mikhail et al.
CURRENT DRUG SAFETY (2009)
Prescribers' knowledge of and sources of information for potential drug-drug interactions - A postal survey of US prescribers
Yu Ko et al.
DRUG SAFETY (2008)
Under-reporting of adverse drug reactions - A systematic review
Lorna Hazell et al.
DRUG SAFETY (2006)
Two probable cases of serious drug interaction between clarithromycin and colchicine
VCC Cheng et al.
SOUTHERN MEDICAL JOURNAL (2005)
The reporting odds ratio and its advantages over the proportional reporting ratio
KJ Rothman et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2004)
Share Paper
